To assess the knowledge, attitude and practices in biomedical waste management among health care workers in dedicated COVID hospital in Bangalore
TJ Basavaraj, BL Shashibhushan… - The Egyptian Journal of …, 2021 - Springer
Background In this pandemic of COVID-19, the highest amount of infective material, biomedical
waste is generated in hospitals and it is frequently handled by the healthcare workers …
waste is generated in hospitals and it is frequently handled by the healthcare workers …
Pattern of drug-resistance and treatment outcome in multidrug-resistant pulmonary tuberculosis.
C Nagaraja, BL Shashibhushan, M Asif… - The Indian journal of …, 2012 - europepmc.org
Aims and objectives To study the pattern of drug-resistance and treatment outcomes among
patients with confirmed multidrug-resistant pulmonary tuberculosis (MDR-PTB). Methods A …
patients with confirmed multidrug-resistant pulmonary tuberculosis (MDR-PTB). Methods A …
Hydrogen peroxide in exhaled breath condensate: A clinical study
C Nagaraja, BL Shashibhushan, M Asif… - Lung India, 2012 - journals.lww.com
Objectives: To study the ongoing inflammatory process of lung in healthy individuals with risk
factors and comparing with that of a known diseased condition. To study the inflammatory …
factors and comparing with that of a known diseased condition. To study the inflammatory …
[HTML][HTML] Efficacy and safety of pegylated interferon-α2b in moderate COVID-19: a phase 3, randomized, comparator-controlled, open-label study
SB BL, S Wanve, P Koradia, V Bhomia, P Soni… - International Journal of …, 2021 - Elsevier
Objective To evaluate the efficacy and safety of pegylated interferon alpha-2b (PEG IFN-α2b)
administered in conjunction with the standard of care (SOC) in subjects with moderate …
administered in conjunction with the standard of care (SOC) in subjects with moderate …
Advanced 3D In Vitro Lung Fibrosis Models: Contemporary Status, Clinical Uptake, and Prospective Outlooks
N Jain, BL Shashi Bhushan, M Natarajan… - ACS Biomaterials …, 2024 - ACS Publications
Fibrosis has been characterized as a global health problem and ranks as one of the primary
causes of organ dysfunction. Currently, there is no cure for pulmonary fibrosis, and limited …
causes of organ dysfunction. Currently, there is no cure for pulmonary fibrosis, and limited …
Resistance pattern in drug-resistant pulmonary tuberculosis
C Nagaraja, BL Shashibhushan, C Sagar… - Journal of …, 2011 - journals.lww.com
Background: Drug-resistant tuberculosis is an important issue for public health. There is a
rise in the trend of drug-resistant tuberculosis, especially multi drug resistance (MDR), in …
rise in the trend of drug-resistant tuberculosis, especially multi drug resistance (MDR), in …
Randomized, Comparative, Clinical Trial to Evaluate Efficacy and Safety of PNB001 in Moderate COVID-19 Patients
E Lattmann, P Bhalerao, BL ShashiBhushan… - medRxiv, 2021 - medrxiv.org
Objective To evaluate the efficacy and safety of PNB001 a CCK-A agonist and CCK-B antagonist,
a new chemical entity with anti-inflammatory and immune stimulation properties, along …
a new chemical entity with anti-inflammatory and immune stimulation properties, along …
[HTML][HTML] Comparative Study of Systemic Inflammatory Markers in Clinical Phenotypes of Chronic Obstructive Pulmonary Disease
M Sonar, BT Jayadeva, BL Shashibhushan - Tanaffos, 2023 - ncbi.nlm.nih.gov
Background: Chronic Obstructive Pulmonary Disease (COPD) is an inflammatory pulmonary
disorder with systemic inflammatory manifestations. This study aims to identify the profile of …
disorder with systemic inflammatory manifestations. This study aims to identify the profile of …
Randomized, Comparative, Clinical Trial to Evaluate Efficacy and Safety of PNB001 in Moderate COVID-19 Patients (preprint)
E Lattman, P Bhalerao, BL ShashiBhushan… - 2021 - pesquisa.bvsalud.org
Objective: To evaluate the efficacy and safety of PNB001 a CCK-A agonist and CCK-B
antagonist, a new chemical entity with anti-inflammatory and immune stimulation properties, …
antagonist, a new chemical entity with anti-inflammatory and immune stimulation properties, …
Knowledge, attitude, and practice of coronavirus disease 2019 disease among patients attending coronavirus disease 2019-screening OPD
KU Vivek, BL Shashibhushan… - The Egyptian Journal of …, 2022 - journals.lww.com
Objective To study the knowledge, attitude, and practice of patients toward COVID-19, this
in turn helps to take necessary actions to prevent COVID-19-infection spread in the country. …
in turn helps to take necessary actions to prevent COVID-19-infection spread in the country. …